We are pleased to announce that Dr. Jörg Taubel, will be one of the faculty members at the upcoming course tailored for postgraduates in life sciences interested in early clinical development of medicinal products.

This comprehensive course consists of two parts, spanning several days, providing an in-depth overview of Human Pharmacology and Translational Medicine. The curriculum covers essential topics from non-clinical pharmacology and toxicology to first-in-man studies and proof-of-concept clinical trials.

To find out more, click here:

Latest news

Richmond Strengthens ESG Commitment Through Sustainability Accelerator Programme

February 17, 2025
We are committed to embedding Environmental, Social, and Governance (ESG) principles into our clinical research operations to drive responsible and sustainable business growth...
Read more

Trial That Could Revolutionise Cardiac Safety Studies – Research Consortium Calls For Others To Join

February 10, 2025
The US-based Cardiac Safety Research Consortium has endorsed a project aimed at replacing the routine use of drugs...
Read more

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

April 7–11
Exploring advancements shaping the future of healthcare.
View event